Frazier Financial Advisors LLC Grows Position in Bath & Body Works, Inc. (NYSE:BBWI)

Frazier Financial Advisors LLC boosted its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 4.2% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 41,082 shares of the company’s stock after purchasing an additional 1,645 shares during the period. Bath & Body Works makes up about 1.0% of Frazier Financial Advisors LLC’s portfolio, making the stock its 15th biggest position. Frazier Financial Advisors LLC’s holdings in Bath & Body Works were worth $1,311,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently bought and sold shares of BBWI. First Community Trust NA acquired a new stake in Bath & Body Works during the 2nd quarter valued at approximately $30,000. Livforsakringsbolaget Skandia Omsesidigt lifted its stake in Bath & Body Works by 300.0% during the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after acquiring an additional 900 shares during the period. GAMMA Investing LLC lifted its stake in Bath & Body Works by 65.4% during the 2nd quarter. GAMMA Investing LLC now owns 1,846 shares of the company’s stock valued at $72,000 after acquiring an additional 730 shares during the period. EntryPoint Capital LLC lifted its stake in Bath & Body Works by 224.0% during the 1st quarter. EntryPoint Capital LLC now owns 1,471 shares of the company’s stock valued at $74,000 after acquiring an additional 1,017 shares during the period. Finally, Abich Financial Wealth Management LLC acquired a new stake in Bath & Body Works during the 3rd quarter valued at approximately $103,000. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Insider Activity at Bath & Body Works

In other news, CEO Gina Boswell acquired 6,000 shares of the company’s stock in a transaction that occurred on Wednesday, October 9th. The stock was purchased at an average price of $29.64 per share, with a total value of $177,840.00. Following the completion of the acquisition, the chief executive officer now owns 242,987 shares of the company’s stock, valued at $7,202,134.68. This trade represents a 2.53 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.27% of the stock is currently owned by insiders.

Bath & Body Works Stock Up 0.7 %

Bath & Body Works stock opened at $31.54 on Friday. Bath & Body Works, Inc. has a 52-week low of $26.20 and a 52-week high of $52.99. The firm has a market capitalization of $6.91 billion, a price-to-earnings ratio of 7.64, a PEG ratio of 1.00 and a beta of 1.79. The company has a fifty day simple moving average of $30.18 and a 200-day simple moving average of $36.43.

Bath & Body Works (NYSE:BBWI) last released its earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. The business had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.54 billion. On average, research analysts anticipate that Bath & Body Works, Inc. will post 3.18 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 22nd will be issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.54%. The ex-dividend date is Friday, November 22nd. Bath & Body Works’s dividend payout ratio is currently 19.37%.

Analyst Upgrades and Downgrades

BBWI has been the subject of several analyst reports. Citigroup decreased their target price on shares of Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating for the company in a research note on Tuesday, August 20th. Wells Fargo & Company decreased their target price on shares of Bath & Body Works from $35.00 to $32.00 and set an “equal weight” rating for the company in a research note on Wednesday, November 6th. The Goldman Sachs Group decreased their target price on shares of Bath & Body Works from $60.00 to $49.00 and set a “buy” rating for the company in a research note on Thursday, August 29th. Robert W. Baird decreased their target price on shares of Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating for the company in a research note on Thursday, August 29th. Finally, Bank of America decreased their target price on shares of Bath & Body Works from $54.00 to $45.00 and set a “buy” rating for the company in a research note on Thursday, August 29th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and nine have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $42.44.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.